test

Irshad Karim

@Lion Point Capital, Lp

Latest period2024 - Q3ReportedManaged Assets$44.907MTotal holdings25
Assets growth rate-18.13%Assets growth rate (2-Q avg)-43.74%Continuous growth in asset value0 quarters

Portfolio positions

This chart displays the top 10 holdings in Lion Point Capital, Lp's 2024 - Q3 portfolio, based on their 13F SEC filing, out of a total of 25 positions.

Assets under management

The assets under management (AUM) of Lion Point Capital, Lp over the past 10 years (40 quarters) show continuous growth in total asset value over the last 0 quarters. As of the latest 13F SEC filing for 2024 - Q3, they manage 44.907M in assets, with a quarterly growth rate of -18.13% and a 2-quarter average growth rate of -43.74%. The portfolio is managed by Irshad Karim, and others.

Portfolio holdings

CurrentNew PositionIncreasedDecreasedExited
InvestmentPortfolio %Reported Value
IWMIshares Tr
Recent Activity
40.59%
$18.223M↓ Put
82,500 shares@ $220.89 avg price
INSMInsmed Inc
Recent Activity
Decreased -25.78%
8.49%
$3.811M
52,200 shares@ $73.0 avg price
GERNGeron Corp
Recent Activity
6.37%
$2.86M
630,000 shares@ $4.54 avg price
ARDXArdelyx Inc
Recent Activity
Decreased -56.8%
5.68%
$2.549M
370,000 shares@ $6.89 avg price
MISTMilestone Pharmaceuticals In
Recent Activity
Decreased -29.31%
5.6%
$2.514M
1.654M shares@ $1.52 avg price
BHVNBiohaven Ltd
Recent Activity
New Position
3.94%
$1.769M
35,400 shares@ $49.97 avg price
MIRMMirum Pharmaceuticals Inc
Recent Activity
3.91%
$1.755M↓ Put
45,000 shares@ $39.0 avg price
KNSAKiniksa Pharmaceuticals Ltd
Recent Activity
Decreased -41.35%
3.42%
$1.534M
61,400 shares@ $24.99 avg price
BBIOBridgebio Pharma Inc
Recent Activity
2.78%
$1.248M
49,000 shares@ $25.46 avg price
MRNSMarinus Pharmaceuticals Inc
Recent Activity
Decreased -67.19%
2.72%
$1.221M
693,778 shares@ $1.76 avg price